Procter & Gamble Health P/E Ratio
Current P/E Ratio
31.96
High Valuation
Very High - High growth expectations or significantly overvalued
Procter & Gamble Health (PGHL) P/E ratio is 31.96 (High), EPS (TTM) ₹141.00, current price ₹6247.50 on NSE — Very High - High growth expectations or significantly overvalued. Browse PGHL cash flow statement for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
P/E Ratio
31.96
Current Price
₹6247.50
EPS (TTM)
₹141.00
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.14
Sector Median
28.77
Sector Rank
#11 of 193
Sector Percentile
5.7%
PGHL P/E Ratio — Valuation Signal & Historical Context
Procter & Gamble Health P/E 31.96 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Procter & Gamble Health screener.
- Stock appears overvalued with PE of 31.96, suggesting caution for new investments
- Trading at discount to sector average PE of 49.14
PGHL vs Healthcare Peers — P/E Ratio Comparison
Procter & Gamble Health P/E 31.96 vs Healthcare average 49.14, median 28.77 — range 0.97–869.57.
Sector Average
49.14
Sector Median
28.77
Lowest P/E
0.97
Highest P/E
869.57
Companies
193
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |